Kairos Pharma, LTD. (KAPA) is a pharmaceutical preparations company incorporated in DE, listed on the NYSE. With a market capitalization of $13 million, Kairos Pharma, LTD. is a micro-cap company. The stock currently trades at $0.62, up 3.19% today, with a 52-week range of $0.40–$2.11.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.23 | $-0.23 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-04-15 | 0001641172-25-004920 | SEC ↗ |